Effect of vaccines in a murine model of dormant tuberculosis
- 1 February 1994
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 75 (1) , 61-64
- https://doi.org/10.1016/0962-8479(94)90105-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentJournal of Antimicrobial Chemotherapy, 1993
- Understanding the chemotherapy of tuberculosis—current problemsJournal of Antimicrobial Chemotherapy, 1992
- Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosisTubercle and Lung Disease, 1992
- Immunotherapy of tuberculosisTubercle, 1990
- Immunity to tuberculosis from the perspective of pathogenesisInfection and Immunity, 1989
- Controlled Clinical Trial of Levamisole in Short-course Chemotherapy for Pulmonary Tuberculosis: A Kenyan/Zambian/British Medical Research Council Collaborative StudyAmerican Review of Respiratory Disease, 1989
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South IndiaTubercle, 1983
- Immunological memory in tuberculosis: I. Influence of persisting viable organismsCellular Immunology, 1974
- MICROBIAL PERSISTENCEThe Journal of Experimental Medicine, 1966